Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Indices offer a practical way to quantify risk exposure and monitor changes over time, supporting proactive adjustments.
27,018 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Dogecoin strengthens its footing as ETF inflows stay in positive territory through May, with key resistance near $0.1...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...
Bitcoin topped near $82,400 on May 20, 2026, then pulled back to around $76,000 after hitting a closely watched chart...
As Autohome reports Q1 2026 earnings, investors get a clear read on user momentum, ad revenue, and margin discipline....
Nebius just announced a strategic partnership aimed at easing power bottlenecks in its AI infrastructure rollout. Thi...
As Torrid approaches its 2026 earnings moment, investors seek signals on growth, margins, and the road to improved pr...
As UNFI approaches its 2026 earnings call, investors want clarity on margins, growth drivers, and capital strategy. T...
Micron Technology’s earnings beat lifts tech shares and helps the Nasdaq Composite rebound. Markets weigh mixed infla...
June data showed payroll gains stalled while prime-age participation fell, signaling hidden weakness beneath the surf...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
Meta Platforms appears poised for a potential move toward $700 as earnings beat and AI-driven monetization clash with...